Novel Therapeutics
Estrogen Neuroprotection Independent of Hormonal Action
Published in Neurological Diseases and Disorders Weekly, August 16th, 1999
The finding paves the way for the creation of new drugs for Alzheimer's disease (AD) and other diseases in which oxidative neuronal cell death occurs.
"These results ... may open the door toward the rational design of neuroprotective antioxidants with decreased hormonal side effects," suggested Bernd Moosmann and Christian Behl of the Max Planck Institute of Psychiatry, Munich, Germany.
Moosmann and Behl reported their findings in the Proceedings of the National Academy of Sciences ("The Antioxidant Neuroprotective Effects of Estrogens and Phenolic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Neurological Diseases and Disorders Weekly
More Articles from Neurological Diseases and Disorders Weekly
- Novel Therapeutics
Nuclear-Factor Activation Protects Neurons Against Plaque - Animal Models
Amyloid Precursor Protein Alters Hypoxic Recovery - Animal Models
SAM Has Some, Not All, of the Alzheimer's Characteristics - Genetics
Late-Onset AD Associated with Genetic Variability - Genetics
Missense Mutation Animal Model Furthers AD Studies - Parkinson's Disease
Engineered Astrocytes Show Promise as Therapy - More from this issue of Neurological Diseases and Disorders Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
